Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Mouse CHIT1 Polyclonal Antibody

Catalog #:   PMG45101 Specific References (42) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: Q9D7Q1
Overview

Catalog No.

PMG45101

Species reactivity

Mouse

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Mouse CHIT1 (Lys23-Leu383).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)

Purification

Purified by antigen affinity column.

Accession

Q9D7Q1

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with CHIT1 antibody (PMG45101) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 42 kDa
    Observed MW: 42 kDa
References

Biological signatures in the Alzheimer's continuum discriminate between diagnosis-related and -unrelated associations to ATN categories., PMID:40046342

Thyroid Function and Morphology in Gaucher Disease: Exploring the Endocrine Implications., PMID:39769400

Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis., PMID:38527011

A Brazilian Rare-Disease Center's Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF., PMID:38474117

A child with polyarthritis and chronic lung disease: a case report of ataxia-telangiectasia., PMID:37667293

Plasma levels of multiple cardiovascular- and inflammation-related proteins analysed for associations with disease activity and anti-cyclic citrullinated peptide status in active early rheumatoid arthritis., PMID:36995323

Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis., PMID:35370755

Duplication mutation in CHIT1 gene is associated with poor response to medical therapy in patients affected with filarial chyluria., PMID:34621114

Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers., PMID:32849633

Use of glycerol and propylene glycol as additives in heat-treated goat colostrum., PMID:31882214

Biomarkers and newer laboratory investigations in the diagnosis of sepsis., PMID:31497788

Sheep and goats raised in mixed flocks have diverse immune status around parturition., PMID:31255264

Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease., PMID:31092718

NOD2 expression, DNA damage and oxido-inflammatory status in atopic bronchial asthma: Exploring their nexus to disease severity., PMID:29572197

Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months., PMID:29305734

The Role of Fungi in the Etiology of Multiple Sclerosis., PMID:29085329

Does 24bp Duplication of Human CHIT1 Gene (Chitotriosidase1) Predispose to Filarial Chyluria? A Case-Control Study., PMID:27790506

Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis., PMID:27787906

Development of anti-velaglucerase alfa antibodies in clinical trial-treated patients with Gaucher disease., PMID:27282565

Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase., PMID:27102949

Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency., PMID:26049896

Seven-year safety and efficacy with velaglucerase alfa for treatment-naïve adult patients with type 1 Gaucher disease., PMID:25903392

Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials., PMID:25801797

Safety and efficacy results of switch from imiglucerase to velaglucerase alfa treatment in patients with type 1 Gaucher disease., PMID:25776130

The effect of colostrum source (goat vs. sheep) and timing of the first colostrum feeding (2h vs. 14h after birth) on body weight and immune status of artificially reared newborn lambs., PMID:25468691

Determination of chitinases family during osteoclastogenesis., PMID:24440516

Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis., PMID:24212238

From goat colostrum to milk: physical, chemical, and immune evolution from partum to 90 days postpartum., PMID:24183682

Chitotriosidase is a biomarker for the resistance to World Trade Center lung injury in New York City firefighters., PMID:23744081

Association of genetic variation in chitotriosidase with atopy in Korean children., PMID:23706714

Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials., PMID:22785399

Effects of induced parturition in goats on immunoglobulin G and chitotriosidase activity in colostrum and plasma and on plasma concentrations of prolactin., PMID:21288684

Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis., PMID:19925532

Effect of colostrum immunoglobulin concentration on immunity in Majorera goat kids., PMID:19307651

Treatment of Fabry disease with different dosing regimens of agalsidase: effects on antibody formation and GL-3., PMID:18424138

Effect of treatment on biclonal gammopathy associated with Gaucher disease., PMID:17879146

Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy., PMID:16765076

Assessment of relations between clinical outcome of ischemic stroke and activity of inflammatory processes in the acute phase based on examination of selected parameters., PMID:15956787

Type I Gaucher disease with severe skeletal destruction, extraosseous extension, and monoclonal gammopathy., PMID:15551278

Enzyme therapy of gaucher disease: clinical and biochemical changes during production of and tolerization for neutralizing antibodies., PMID:12667990

[Gaucher's disease ]., PMID:12360743

Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease., PMID:9382473

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Mouse CHIT1 Polyclonal Antibody [PMG45101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only